Legal – Talk Bio

Harvard Faces $2.2 Billion Federal Funding Freeze After Defying Trump Administration Demands

1 week ago talkbio0Tagged Academia (organization), Administration occupational activities, antisemitism, battle, campus, civil, DEI, Diversity, federal, Freezing, Harvard University, Legal, protest, Research Projects, R-Series, Status, Transplant Registry Unified Management Program, university governance

Harvard University, Trump administration, federal funding freeze, $2.2 billion, research grants, diversity equity inclusion (DEI), antisemitism, academic independence, campus protests, Title VI, civil rights, university governance, legal battle, tax exempt status

Federal Judge Blocks NIH Grant Caps as HHS Appeals Ruling

2 weeks ago talkbio0Tagged Administration occupational activities, Administrative Procedure Act, appeal, CHARGE Syndrome, federal judge, Health Policy, Indirect, injunction, Legal, Medical Research activity, NIH Mouse, Permanent, research, Transplant Registry Unified Management Program, U.S., United States

NIH, HHS, research funding, grant caps, indirect costs, federal judge, permanent injunction, Trump administration, medical research, Administrative Procedure Act, legal appeal, U.S. healthcare policy.

Legal Battle Erupts as Deerfield Accuses Alcon of Obstructing Aurion Biotech’s IPO Plans

2 months ago talkbio0Tagged Alcon, biotech, biotech industry, Bovichtus, Chancery, Corporate, court, Deerfield Management, Delaware, governance, IPO, Legal, Public Offering, research, shareholder

Aurion Biotech, Alcon Research, Deerfield Management , Initial Public Offering (IPO), Legal dispute, Biotech industry, Corporate governance, Shareholder rights, Delaware Court of Chancery

NIHs funding cut plan poses challenges for researchers despite court halt

2 months ago talkbio0Tagged Impact food supplement, Indirect, Legal, NIH Mouse, Research Projects, R-Series, Science

NIH funding cuts, indirect costs, research grants, legal challenges, scientific community impact

Aurion Biotech Presses On with IPO Plans Amid Legal Dispute with Investor Alcon

3 months ago talkbio0Tagged Alcon, biotech, Bovichtus, Cell Therapy, Investments, IPO, Legal

Aurion Biotech, IPO, legal dispute, Alcon, cell therapy, biotech investment

Amgen Faces Investor Lawsuit Over $10.7 Billion Tax Liability

7 months ago talkbio0Tagged amgen, investor, Legal

Amgen, investor lawsuit, tax liability, $10.7 billion, legal challenge

The Post-Chevron Regulatory Landscape: Implications for the FDA and Healthcare Industry

8 months ago talkbio0Tagged Administrative procedure, Boards (medical device), Chevron Deference, Corner Post, court, Federal Reserve System, Governors, Healthcare Industry, judicial, Landscapes, Legal, Loper Bright Enterprises, Raimondo, regulatory, Supreme, United States Food and Drug Administration

Chevron deference, FDA, regulatory landscape, healthcare industry, Supreme Court ruling, Loper Bright Enterprises v. Raimondo, Corner Post, Inc. v. Board of Governors of the Federal Reserve System, Administrative Procedure Act (APA), judicial scrutiny, legal challenges, regulatory implications.